Health & Personal Care
HIGH
FDA DRUG
Glenmark Pharmaceuticals Recalls Theophylline Tablets Over Dissolution Issues
Glenmark Pharmaceuticals Inc. recalled 22,656 bottles of Theophylline extended-release tablets on August 8, 2025. The recall follows reports of failed dissolution specifications that could impact medication efficacy. Consumers should stop using the product and consult healthcare providers immediately.
Glenmark Pharmaceuticals Inc.
Failed Dissolution